Vitamin D supplementation and outcomes in coronavirus disease 2019 (COVID-19) patients from the outbreak area of Lombardy, Italy
et al., Nutrition, doi:10.1016/j.nut.2020.111055
, Vitamin D supplementation and outcomes in coronavirus disease 2019 (COVID-19) patients from the outbreak area.., Nutrition, doi:10.1016/j.nut.2020.111055
Retrospective 105 Parkinson's disease patients, 92 caregivers, and 127 hospital inpatients, showing higher, but not statistically significant mortality and hospitalization with treatment. Supplementation was defined as >=25,000IU/month for at least 3 months.
|
risk of death, 73.0% higher, RR 1.73, p = 0.14, treatment 7 of 18 (38.9%), control 40 of 152 (26.3%), odds ratio converted to relative risk, >=25,000IU/month for at least 3 months.
|
|
risk of hospitalization, 17.3% higher, RR 1.17, p = 0.68, treatment 7 of 27 (25.9%), control 36 of 170 (21.2%), odds ratio converted to relative risk.
|
| Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates |
Cereda et al., 11 Nov 2020, retrospective, Italy, peer-reviewed, mean age 68.8, 7 authors, dosage varies.
Abstract: Since January 2020 Elsevier has created a COVID-19 resource centre with
free information in English and Mandarin on the novel coronavirus COVID19. The COVID-19 resource centre is hosted on Elsevier Connect, the
company's public news and information website.
Elsevier hereby grants permission to make all its COVID-19-related
research that is available on the COVID-19 resource centre - including this
research content - immediately available in PubMed Central and other
publicly funded repositories, such as the WHO COVID database with rights
for unrestricted research re-use and analyses in any form or by any means
with acknowledgement of the original source. These permissions are
granted for free by Elsevier for as long as the COVID-19 resource centre
remains active.
Nutrition 82 (2021) 111055
Contents lists available at ScienceDirect
Nutrition
journal homepage: www.nutritionjrnl.com
Applied nutritional investigation
Vitamin D supplementation and outcomes in coronavirus disease 2019
(COVID-19) patients from the outbreak area of Lombardy, Italy
Emanuele Cereda M.D., Ph.D. a,*, Laura Bogliolo M.D. b, Federica Lobascio M.D. a,
Michela Barichella M.D. c,d, Anna Lena Zecchinelli M.D. e, Gianni Pezzoli M.D. d,e,
Riccardo Caccialanza M.D. a
a
Clinical Nutrition and Dietetics Unit, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
Rheumatology Unit, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
c
UOS Clinical Nutrition, ASST “Gaetano Pini-CTO”, Milan, Italy
d
Fondazione Grigioni per il Morbo di Parkinson, Milano, Italy
e
Parkinson Institute, ASST “Gaetano Pini-CTO”, Milan, Italy
b
A R T I C L E
I N F O
Article History:
Received 1 September 2020
Received in revised form 3 November 2020
Accepted 3 November 2020
Keywords:
Vitamin D
Coronavirus (SARS-CoV-2)
COVID-19
Hospitalization
Mortality
Outcome
Loading..
Please send us corrections, updates, or comments. Vaccines and
treatments are complementary. All practical, effective, and safe means should
be used based on risk/benefit analysis. No treatment, vaccine, or intervention
is 100% available and effective for all current and future variants. We do not
provide medical advice. Before taking any medication, consult a qualified
physician who can provide personalized advice and details of risks and
benefits based on your medical history and situation. FLCCC and WCH
provide treatment protocols.